These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 31542055

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A, Yacouba A, Bamba S, Sangare I, Sawadogo M, Guiguemde T, Kone S, Traore LK, Ouedraogo-Traore R, Guiguemde RT.
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [Abstract] [Full Text] [Related]

  • 6. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S, Hofmann H.
    Mycoses; 1997 Dec; 40 Suppl 1():56-63. PubMed ID: 9417515
    [Abstract] [Full Text] [Related]

  • 7. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.
    Arias A, Arévalo MP, Andreu A, Rodríguez C, Sierra A.
    Mycoses; 1994 Dec; 37(7-8):285-9. PubMed ID: 7739661
    [Abstract] [Full Text] [Related]

  • 8. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N, Alem N.
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [Abstract] [Full Text] [Related]

  • 9. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI, Ogbonnaya UL.
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E, Parras P, Lozano MC.
    Chemotherapy; 1992 Jun; 38(5):335-9. PubMed ID: 1337508
    [Abstract] [Full Text] [Related]

  • 11. Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
    Silva V, Alvarado D, Diaz MC.
    Med Mycol; 2004 Jun; 42(3):283-5. PubMed ID: 15283244
    [Abstract] [Full Text] [Related]

  • 12. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
    Kooshki P, Rezaei-Matehkolaei A, Mahmoudabadi AZ.
    J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
    [Abstract] [Full Text] [Related]

  • 13. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S.
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [Abstract] [Full Text] [Related]

  • 14. Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
    Ellepola AN, Chandy R, Khan ZU.
    J Investig Clin Dent; 2015 Aug; 6(3):186-92. PubMed ID: 24850753
    [Abstract] [Full Text] [Related]

  • 15. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [Abstract] [Full Text] [Related]

  • 16. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility of candida isolates from denture-related stomatitis to antifungal agents in vitro.
    Dorocka-Bobkowska B, Konopka K.
    Int J Prosthodont; 2007 Jul; 20(5):504-6. PubMed ID: 17944341
    [Abstract] [Full Text] [Related]

  • 18. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT, Findik D, Senkeles C, Arslan U.
    Ann Clin Microbiol Antimicrob; 2016 May 31; 15(1):36. PubMed ID: 27245756
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.
    Quindós G, Carrillo-Muñoz AJ, Arévalo MP, Salgado J, Alonso-Vargas R, Rodrigo JM, Ruesga MT, Valverde A, Pemán J, Cantón E, Martín-Mazuelos E, Pontón J.
    Chemotherapy; 2000 May 31; 46(6):395-401. PubMed ID: 11053905
    [Abstract] [Full Text] [Related]

  • 20. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.
    Sojakova M, Liptajova D, Borovsky M, Subik J.
    Mycopathologia; 2004 Feb 31; 157(2):163-9. PubMed ID: 15119851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.